ALK

同壁财经 · May 22 at 05:36 AM

Dragon and Tiger List | ALK (002940) hit the limit down, with the top 5 sell orders totaling 123 million yuan. Reason for being on the list: The daily decline deviation reached 7% for the top 5 securities

Wallstreetcn · Mar 31 at 09:07 PM

Innovative drug concept repeatedly active, ALK straight to the daily limit, Rundu Pharma previously sealed the board, InventisBio, Junshi Biosciences, HWPC, and Biokin Pharmaceutical rose more than 6%

Zhitong · Nov 2, 2025 at 07:48 PM

A-share innovative drug concept stocks are active again, Sunshine Guojian Pharmaceutical rose over 10% to a new high, Yatai Pharm had two consecutive limit-ups, WECOME rose over 10%, and Baicheng Pharmaceutical, ALK, and Fushine followed suit

Zhitong · Oct 29, 2025 at 10:15 PM

ALK: Starting in 2026, research and development investment will focus more on innovative drug projects

Zhitong · Oct 28, 2025 at 06:45 AM

ALK: Subsidiary obtains approval number for "Amoxicillin Clavulanate Potassium Tablets" veterinary drug product

Zhitong · Oct 24, 2025 at 11:53 AM

ALK released its performance for the first three quarters, with a net profit attributable to the parent company of 77.6899 million yuan, a year-on-year increase of 55.59%